Cannabis rescheduling is still a proposal, not a finished rule. The Justice Department proposed moving marijuana from Schedule I to Schedule III of the Controlled Substances Act, and the Drug Enforcement Administration moved that proposal into formal administrative hearings. No final order has taken effect, so marijuana remains Schedule I federally, and hemp-derived CBD remains legal under the 2018 Farm Bill.
New Updates on Cannabis Rescheduling: What You Need to Know
What does cannabis rescheduling actually mean?
Rescheduling means changing which schedule of the Controlled Substances Act a substance sits in. Schedule I is reserved for drugs with no currently accepted medical use and a high potential for abuse. Schedule III covers drugs with moderate to low physical dependence potential and a recognized medical use, such as ketamine and Tylenol with codeine.
Moving marijuana to Schedule III would not legalize it. It would acknowledge medical use and loosen some federal controls, while state laws would still govern retail sales.
What is the latest status of the rescheduling process?
The proposed rule is in the administrative hearing phase, where designated administrative law judges take testimony from supporters and opponents. Those hearings test whether the scientific and medical record supports a Schedule III placement. After the hearings, a final rule would need review and publication, and court challenges are expected either way.
How would Schedule III affect cannabis businesses?
- Section 280E tax limits would ease for state-licensed operators, since the restriction targets Schedule I and II substances.
- Banking, insurance, and research access would likely improve.
- Federal penalties for unlicensed production and distribution would remain.
Does cannabis rescheduling change CBD rules?
Hemp-derived CBD containing no more than 0.3 percent delta-9 THC by dry weight is already excluded from the controlled substance schedules. That legal status comes from the 2018 Farm Bill, not from marijuana scheduling decisions. Rescheduling marijuana would not loosen FDA rules for CBD products, and it would not override state hemp regulations.
A separate debate over intoxicating hemp cannabinoids may affect the CBD market more than rescheduling does. Lawmakers have weighed tighter hemp definitions in farm bill negotiations.
What should CBD shoppers watch next?
- A final DEA rule and any court appeals.
- Farm Bill language on hemp-derived cannabinoids.
- FDA enforcement priorities for CBD labeling and claims.
- State laws that add age limits or product caps.
Until a final rule is published, buy from brands that post batch-specific certificates of analysis and stay within your state's hemp rules.